OsteoCentric Oncology and Bone Anchored Prostheses, LLC, a subsidiary of OsteoCentric Technologies, Inc., has made a public offer for all shares in Integrum AB (publ). The offer values all shares in Integrum at approximately SEK 939 million.
Vinge’s team consists of Erik Sjöman, Sofie Bjärtun, Linnéa Dolk and Michaela Ådén (Capital Markets and Public M&A) and Daniel Wendelsson, Fredrik Hellström and Lovisa Arpi (FDI).
